Journal article
Survival implications associated with variation in mastectomy rates for early-staged breast cancer
International journal of surgical oncology, Vol.2012, pp.1-9
2012
DOI: 10.1155/2012/127854
PMCID: PMC3423912
PMID: 22928097
Abstract
Despite a 20-year-old guideline from the National Institutes of Health (NIH) Consensus Development Conference recommending breast conserving surgery with radiation (BCSR) over mastectomy for woman with early-stage breast cancer (ESBC) because it preserves the breast, recent evidence shows mastectomy rates increasing and higher-staged ESBC patients are more likely to receive mastectomy. These observations suggest that some patients and their providers believe that mastectomy has advantages over BCSR and these advantages increase with stage. These beliefs may persist because the randomized controlled trials (RCTs) that served as the basis for the NIH guideline were populated mainly with lower-staged patients. Our objective is to assess the survival implications associated with mastectomy choice by patient alignment with the RCT populations. We used instrumental variable methods to estimate the relationship between surgery choice and survival for ESBC patients based on variation in local area surgery styles. We find results consistent with the RCTs for patients closely aligned to the RCT populations. However, for patients unlike those in the RCTs, our results suggest that higher mastectomy rates are associated with reduced survival. We are careful to interpret our estimates in terms of limitations of our estimation approach.
Details
- Title: Subtitle
- Survival implications associated with variation in mastectomy rates for early-staged breast cancer
- Creators
- John M BrooksElizabeth A ChrischillesMary Beth LandrumKara B WrightGang FangEric P WinerNancy L Keating
- Resource Type
- Journal article
- Publication Details
- International journal of surgical oncology, Vol.2012, pp.1-9
- DOI
- 10.1155/2012/127854
- PMID
- 22928097
- PMCID
- PMC3423912
- NLM abbreviation
- Int J Surg Oncol
- ISSN
- 2090-1410
- eISSN
- 2090-1410
- Grant note
- DOI: 10.13039/100000054, name: National Cancer Institute, award: R01 CA104118
- Language
- English
- Date published
- 2012
- Academic Unit
- Pharmacy; Epidemiology
- Record Identifier
- 9983996074002771
Metrics
18 Record Views